Chen and colleagues [33] investigated the potential synergistic effects of taxol and purvalanol A, two Cdc2/Cdk1 inhibitors, on boosting apoptosis in NSCLC cells. The gene discussed is CDK1; the disease is non-small cell lung carcinoma.